Wellington Management Group LLP reduced its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 0.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,591,160 shares of the insurance provider's stock after selling 8,586 shares during the quarter. Wellington Management Group LLP owned 3.81% of Humana worth $1,454,204,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV raised its stake in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after acquiring an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. lifted its stake in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock worth $28,000 after buying an additional 39 shares during the last quarter. Atwood & Palmer Inc. bought a new stake in shares of Humana during the 3rd quarter worth about $29,000. Ashton Thomas Securities LLC acquired a new position in Humana in the 3rd quarter valued at about $31,000. Finally, Your Advocates Ltd. LLP raised its holdings in Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. Leerink Partnrs downgraded Humana from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, October 2nd. UBS Group lowered their price objective on Humana from $380.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, October 4th. TD Cowen upped their price target on shares of Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Bank of America upgraded shares of Humana from an "underperform" rating to a "neutral" rating and lifted their price objective for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, JPMorgan Chase & Co. increased their target price on shares of Humana from $332.00 to $396.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 21st. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $315.86.
Get Our Latest Stock Report on HUM
Humana Stock Down 0.5 %
Shares of Humana stock traded down $1.33 during trading on Friday, reaching $281.73. 1,751,061 shares of the company traded hands, compared to its average volume of 1,590,764. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market capitalization of $33.92 billion, a PE ratio of 24.95, a P/E/G ratio of 2.27 and a beta of 0.53. The company has a 50 day moving average price of $273.44 and a 200-day moving average price of $327.75. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $488.89.
Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. As a group, equities research analysts expect that Humana Inc. will post 16.14 earnings per share for the current fiscal year.
Humana Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's dividend payout ratio (DPR) is 31.36%.
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.